Jonathan Licht and Keith McCrae to lead new Blood specialty journals

Cell donor’s socioeconomic status shapes cancer treatment outcomes

The socioeconomic status of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation, according to a new study led by researchers at the University of Minnesota Medical School.

July 19, 2024

Vol.50 No.29

Drugs & Targets

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

The Tartu University Hospital, North Estonia Medical Centre, and Icosagen have joined forces to develop and introduce an innovative personalized cell therapy for patients in Estonia.

May 31, 2024

Vol.50 No.22

Clinical Roundup

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.

May 24, 2024

Vol.50 No.21

Clinical Roundup

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

Standard of care treatment for acute myeloid leukemia is safe and effective for adults over 80, according to a study published in Blood Neoplasia. For roughly a quarter of patients, this treatment can durably prolong survival.

May 17, 2024

Vol.50 No.20

Regulatory News

ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence

The FDA Oncologic Drugs Advisory Committee voted 12:2 to recommend approval of the drug imetelstat for a myelodysplastic syndrome indication.

March 15, 2024

Vol.50 No.11

By Jacquelyn Cobb and Paul Goldberg

In Brief

University of Cincinnati opens blood cancer healing center

The University of Cincinnati Cancer Center has opened the Blood Cancer Healing Center, a facility that aims to advance research, treatment, and wellness for blood cancer patients.

February 16, 2024

Vol.50 No.07

Jonathan Licht and Keith McCrae to lead new Blood specialty journals

YOU MAY BE INTERESTED IN

Cell donor’s socioeconomic status shapes cancer treatment outcomes

Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Cyclophosphamide may expand transplant donor pool for patients with blood cancers

Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival

ODAC gives thumbs-up to imetelstat for MDS, upholding the value of transfusion independence

University of Cincinnati opens blood cancer healing center

Renew today!

Subscriber content

Never miss an issue!

Login